Intrinsiqq
Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc. Financials

MD

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 18 available years
Income Statement
TTM
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue$1,959$1,914$2,013$1,995$1,972$1,911
General & Administrative$250$241$238$228$231$263
Total Operating Expenses$1,747$1,705$2,082$1,987$1,799$1,708
Operating Income$213$209-$69$7$173$203
Non-Operating
Net Interest Expense-$13-$17-$35-$38-$36-$55
Other Non-Operating Income (Expense)$4$25$2-$18-$55-$13
EBT (Earnings Before Tax)$203$216-$101-$48$81$135
Income Tax Expense$53$51-$2$12$19$27
Earnings from Continuing Ops––-$99-$60$63$108
Minority Interest––$0$0-$0-$0
Net Income
Net Income$150$165-$99-$60$66$131
Per Share Data
Revenue Per Share$24.57$22.45$24.16$24.27$23.44$22.27
EPS (Basic)$1.89$1.97-$1.19-$0.73$0.79$1.54
EPS (Diluted)$1.84$1.94-$1.19-$0.73$0.79$1.53
Weighted Avg Shares (Basic)77.3M84.1M83.3M82.2M83.5M84.8M
Weighted Avg Shares (Diluted)79.7M85.3M83.3M82.2M84.1M85.8M
Shares Outstanding79.7M85.3M83.3M82.2M84.1M85.8M

Pediatrix Medical Group (MD) financials: revenue, profit and margins

Pediatrix Medical Group (MD) generated about $2.0 billion in revenue and $150 million in net income (a 7.7% net margin) over the trailing twelve months, growing at roughly 2.0% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Pediatrix Medical Group's (MD) revenue?+

Pediatrix Medical Group generated about $2.0 billion in revenue over the trailing twelve months. Revenue has grown at roughly 2.0% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Pediatrix Medical Group profitable?+

Yes, Pediatrix Medical Group reported about $150 million in net income over the trailing twelve months, a net profit margin of roughly 7.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Pediatrix Medical Group's profit margins?+

Pediatrix Medical Group runs an operating margin of about 10.9%, a net margin of about 7.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Pediatrix Medical Group growing?+

Pediatrix Medical Group's revenue has compounded at roughly 2.0% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside MD's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 27 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 30 Oct 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Services-Hospitals · Pick stocks to compare with MD

CompareIntrinsic value
SEMSelect Medical Holdings Corp.
$19.62+1.34%70
EHCEncompass Health Corporation
$141.03+4.63%71
SGRYSurgery Partners Inc.
$23.16+0.13%39
ARDTArdent Health Partners Inc.
$13.19+12.64%53
CYHCommunity Health Systems, Inc.
$2.38+16.10%32
UHSUniversal Health Services, Inc.
$196.46+10.91%80
HCSGHealthcare Services Group Inc.
$26.54+3.79%87
RDNTRadNet Inc.
$80.26+9.67%39

Held by ETFs

MD is in 93 US ETFs. The largest of them, with MD's weight in each:

Spot a number that looks wrong? Check it in MD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MD

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.